Evidence map›Paper›PMID 36408890›Full record

ArticleBiomaterials science2023

pH-Responsive nanofiber buttresses as local drug delivery devices.

Ismail Altinbasak, Salli Kocak, Aaron H Colby, Yasin Alp, Rana Sanyal, Mark W Grinstaff, Amitav Sanyal

Open access · bronzeAbstract read
In one paragraph

Article in Biomaterials science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Chemical science · 2024
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ismail AltinbasakDepartment of Chemistry, Bogazici University, Bebek, Istanbul 34342, Turkey. amitav.sanyal@boun.edu.tr.ORCID http://orcid.org/0000-0003-0073-2538
Salli KocakDepartment of Chemistry, Bogazici University, Bebek, Istanbul 34342, Turkey. amitav.sanyal@boun.edu.tr.
Aaron H ColbyBoston University, Department of Biomedical Engineering, Boston, MA, USA. mgrin@bu.edu.
Yasin AlpDepartment of Chemistry, Bogazici University, Bebek, Istanbul 34342, Turkey. amitav.sanyal@boun.edu.tr.
Rana SanyalDepartment of Chemistry, Bogazici University, Bebek, Istanbul 34342, Turkey. amitav.sanyal@boun.edu.tr.
Mark W GrinstaffBoston University, Department of Biomedical Engineering, Boston, MA, USA. mgrin@bu.edu.ORCID http://orcid.org/0000-0002-5453-3668
Amitav SanyalDepartment of Chemistry, Bogazici University, Bebek, Istanbul 34342, Turkey. amitav.sanyal@boun.edu.tr.ORCID http://orcid.org/0000-0001-5122-8329
Boğaziçi University · TRBoston University · US

Funding

OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADINGFOR TREATING MESOTHELIOMAR01CA232056 · NCI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI COLSON, YOLONDA L, GRINSTAFF, MARK W. · 2019 to 2023
$2.7M
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNGTUMOR RECURRENCER01CA232708 · NCI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI COLSON, YOLONDA L, GRINSTAFF, MARK W. · 2019 to 2023
$2.2M
Treating Peritoneal Malignancies with Paclitaxel-Loaded Expansile NanoparticlesR44CA189215 · NCI · IONIC PHARMACEUTICALS · PI COLBY, AARON HENRY · 2019 to 2020
$2.0M
NCI NIH HHS R01 CA232056NCI NIH HHS R01 CA232708NCI NIH HHS R44 CA189215
6 · The paper itself

Abstract

Electrospun nanofibers are a 3D scaffold of choice for many drug delivery devices due to their high surface area, significant capacity for drug payload, ease of

Indexed as

NanofibersNeoplasmsDoxorubicinDrug Delivery SystemsDrug LiberationHumansHydrogen-Ion ConcentrationPolymersDoxorubicinPolymers

Identifiers

PMID36408890
PMCPMC9930888
OpenAlexW4309509119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.